SCHEMBL16280203

SCHEMBL16280203

Cc1cccc(-n2c3ccccc3c3ccc(Oc4cccc(-n5nc(C)cc5C)c4)c([Pt])c32)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.41
POLB P06746 2/20 0.41
RXFP1 Q9HBX9 2/20 0.41
MAPT P10636 5/20 0.34
L3MBTL1 Q9Y468 3/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
ALDH1A1 P00352 3/20 0.34
ALOX15 P16050 1/20 0.33
SCN9A Q15858 1/20 0.33
KDM4E B2RXH2 3/20 0.32
HPGD P15428 2/20 0.32
HSD17B10 Q99714 1/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
APEX1 P27695 1/20 0.32
MDM2 Q00987 1/20 0.32
USP2 O75604 1/20 0.31
CRHBP P24387 1/20 0.31
CRHR2 Q13324 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16280426 0.91 SMN1; SMN2 (0.41) SMN1; SMN2POLBRXFP1MAPTL3MBTL1
SCHEMBL16280566 0.89 SMN1; SMN2 (0.39) SMN1; SMN2POLBRXFP1MAPTL3MBTL1
SCHEMBL16280372 0.87 SMN1; SMN2 (0.42) SMN1; SMN2POLBRXFP1MAPTL3MBTL1
SCHEMBL16280258 0.87 SMN1; SMN2 (0.39) SMN1; SMN2POLBRXFP1MAPTL3MBTL1
SCHEMBL16280429 0.87 SMN1; SMN2 (0.39) SMN1; SMN2POLBRXFP1MAPTL3MBTL1
SCHEMBL16280381 0.85 SMN1; SMN2 (0.38) SMN1; SMN2POLBRXFP1MAPTL3MBTL1
SCHEMBL16279902 0.85 SMN1; SMN2 (0.39) SMN1; SMN2POLBRXFP1MAPTL3MBTL1
SCHEMBL16280090 0.84 SMN1; SMN2 (0.39) SMN1; SMN2POLBRXFP1L3MBTL1NPC1
SCHEMBL16279881 0.84 SMN1; SMN2 (0.41) SMN1; SMN2POLBRXFP1MAPTL3MBTL1
SCHEMBL16280449 0.83 POLB (0.36) SMN1; SMN2POLBRXFP1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10211414-B2 Phosphorescent tetradentate metal complexes having modified emission spectra ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2019-02-19 US disclosed
US-20170331056-A1 PHOSPHORESCENT TETRADENTATE METAL COMPLEXES HAVING MODIFIED EMISSION SPECTRA ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY 2017-11-16 US disclosed
US-9673409-B2 Phosphorescent tetradentate metal complexes having modified emission spectra ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2017-06-06 US disclosed
WO-2015027060-A1 PHOSPHORESCENT TETRADENTATE METAL COMPLEXES HAVING MODIFIED EMISSION SPECTRA ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2015-02-26 WO disclosed
US-20140364605-A1 PHOSPHORESCENT TETRADENTATE METAL COMPLEXES HAVING MODIFIED EMISSION SPECTRA ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY 2014-12-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170331056-A1 PHOSPHORESCENT TETRADENTATE METAL COMPLEXES HAVING MODIFIED EMISSION SPECTRA AP2S1, PICALM, TRPC3 SMN1; SMN2 2678/4885POLB 2889/4885RXFP1 4793/4885
US-10211414-B2 Phosphorescent tetradentate metal complexes having modified emission spectra AP2S1, PICALM, TRPC3 SMN1; SMN2 2678/4885POLB 2889/4885RXFP1 4793/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.